Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Named SK Life Science LinX, the roughly 530sqm facility is located within the company's US subsidiary, SK Life Science, and ...

Transcell Biologics, led by S. Dravida, is developing AI-powered stem cell testing platforms to replace animal testing in ...

Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration—key factors ...

Biotech firms develop drugs from living organisms; pharma from chemicals. Biotech products require a Biologics License Application for FDA approval. Investing focus should be on the long-term ...

Innovative Pharmaceutical Biotech (HK:0399) has released an update. Innovative Pharmaceutical Biotech Limited has entered into a Memorandum of Understanding to potentially acquire a majority stake in ...

Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large ...

Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash ...

Biotech royalty player Ligand Pharmaceuticals reported a notable insider sale following a year of strong stock performance.

A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Pharmacy vs. Biotechnology: After completing Class 12 (Science stream), students often face the major dilemma of choosing ...